End-of-day quote
Shanghai S.E.
03:30:00 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
34.2
CNY
|
+0.32%
|
|
-8.53%
|
-25.43%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,098
|
10,217
|
40,129
|
18,707
|
9,295
|
6,932
|
-
|
-
|
Enterprise Value (EV)
1 |
7,098
|
10,217
|
40,129
|
18,707
|
9,295
|
6,932
|
6,932
|
6,932
|
P/E ratio
|
23
x
|
39.4
x
|
34.1
x
|
21
x
|
510
x
|
47.5
x
|
29.2
x
|
19.4
x
|
Yield
|
-
|
1.19%
|
0.15%
|
0.33%
|
-
|
0.12%
|
0.18%
|
0.26%
|
Capitalization / Revenue
|
-
|
2.28
x
|
5.69
x
|
2.25
x
|
-
|
1.16
x
|
1.11
x
|
1.06
x
|
EV / Revenue
|
-
|
2.28
x
|
5.69
x
|
2.25
x
|
-
|
1.16
x
|
1.11
x
|
1.06
x
|
EV / EBITDA
|
-
|
-
|
2,42,17,386
x
|
1,59,55,240
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
6,41,96,262
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4.96
x
|
12.9
x
|
4.75
x
|
-
|
1.72
x
|
1.63
x
|
1.51
x
|
Nbr of stocks (in thousands)
|
2,02,680
|
2,02,680
|
2,02,680
|
2,02,680
|
2,02,680
|
2,02,680
|
-
|
-
|
Reference price
2 |
35.02
|
50.41
|
198.0
|
92.30
|
45.86
|
34.20
|
34.20
|
34.20
|
Announcement Date
|
09/04/20
|
29/03/21
|
08/04/22
|
24/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
4,475
|
7,056
|
8,316
|
-
|
5,962
|
6,256
|
6,538
|
EBITDA
|
-
|
-
|
1,657
|
1,172
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
317.1
|
1,490
|
994.4
|
-
|
167
|
272
|
410
|
Operating Margin
|
-
|
7.09%
|
21.12%
|
11.96%
|
-
|
2.8%
|
4.35%
|
6.27%
|
Earnings before Tax (EBT)
1 |
-
|
314.6
|
1,502
|
1,024
|
-
|
169
|
274
|
412
|
Net income
1 |
308.5
|
259.8
|
1,178
|
890.5
|
18.73
|
146
|
237.2
|
356.4
|
Net margin
|
-
|
5.81%
|
16.7%
|
10.71%
|
-
|
2.45%
|
3.79%
|
5.45%
|
EPS
2 |
1.520
|
1.280
|
5.810
|
4.390
|
0.0900
|
0.7200
|
1.170
|
1.760
|
Free Cash Flow
|
-
|
-
|
625.1
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
8.86%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
37.72%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
53.05%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.6000
|
0.3000
|
0.3000
|
-
|
0.0400
|
0.0600
|
0.0900
|
Announcement Date
|
09/04/20
|
29/03/21
|
08/04/22
|
24/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
625
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
18.2%
|
13.4%
|
45.8%
|
25.3%
|
-
|
3.62%
|
5.57%
|
7.74%
|
ROA (Net income/ Total Assets)
|
-
|
7.97%
|
-
|
13.9%
|
-
|
1.9%
|
2.9%
|
4%
|
Assets
1 |
-
|
3,260
|
-
|
6,406
|
-
|
7,682
|
8,178
|
8,910
|
Book Value Per Share
2 |
-
|
10.20
|
15.30
|
19.40
|
-
|
19.90
|
21.00
|
22.70
|
Cash Flow per Share
2 |
-
|
3.910
|
4.730
|
4.180
|
-
|
2.620
|
2.880
|
3.680
|
Capex
1 |
-
|
185
|
335
|
680
|
-
|
789
|
813
|
801
|
Capex / Sales
|
-
|
4.13%
|
4.74%
|
8.18%
|
-
|
13.23%
|
13%
|
12.25%
|
Announcement Date
|
09/04/20
|
29/03/21
|
08/04/22
|
24/04/23
|
25/04/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -25.43% | 952M | | +4.00% | 102B | | -11.26% | 59.57B | | +68.10% | 46.57B | | +11.66% | 36.46B | | +0.42% | 31.75B | | +4.59% | 19.34B | | +14.08% | 16.96B | | +7.06% | 13.37B | | -8.41% | 12.5B |
Other Commodity Chemicals
|